Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA).

Authors:
Peix A; Mesquita CT; Paez D; Pereira CC; Felix R and 10 more

Journal:
Nucl Med Commun

Publication Year: 2014

DOI:
10.1097/MNM.0000000000000143

PMCID:
PMC4076031

PMID:
24781009

Journal Information

Full Title: Nucl Med Commun

Abbreviation: Nucl Med Commun

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest Ernest V. Garcia receives royalties from the sale of the Emory Cardiac Toolbox with SyncTools and AdreviewTools. Dr Garcia also received grant funding from GE Healthcare for the development of MIBG SPECT software (AdreviewTools). He also owns shares of Syntermed Inc. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict-of-interest practice. Dr Mark I. Travin is a consultant to, and has received grant funding from GE Healthcare. Most of the authors were funded by the IAEA as consultants and to travel to a meeting for writing this guidance document"

Evidence found in paper:

"Conflicts of interestErnest V. Garcia receives royalties from the sale of the Emory Cardiac Toolbox with SyncTools and AdreviewTools. Dr Garcia also received grant funding from GE Healthcare for the development of MIBG SPECT software (AdreviewTools). He also owns shares of Syntermed Inc. The terms of this arrangement have been reviewed and approved by Emory University in accordance with its conflict-of-interest practice. Dr Mark I. Travin is a consultant to, and has received grant funding from GE Healthcare. Most of the authors were funded by the IAEA as consultants and to travel to a meeting for writing this guidance document"

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025